Vol. 4 No. 2 (2026), Articles
Vol. 4 No. 2 (2026)

DORI VOSITALARINI TAJRIBADAN O‘TKAZISHDA YO‘L QO‘YILADIGAN XATO VA KAMCHILIKLAR

Articles
Published 2026-02-23
Kibriyeva Maxfirat Abduraxmonovna
Termiz iqtisodiyot va servis unversiteti Morfologik fanlar kafedrasi o’qituvchisi
Raxmatullayev Farxod Muxtorali o’g’li
Tibbiyot fakulteti davolash ishi yo’nalishi talabasi
PDF
DOI

Keywords

Dori vositalari, klinik sinov, preklinik tadqiqot, farmakovigilans, bioetika, randomizatsiya, platsebo nazorati, statistik tahlil, toksikologik tekshiruv, postmarketing kuzatuv, samaradorlik, xavfsizlik.

How to Cite

DORI VOSITALARINI TAJRIBADAN O‘TKAZISHDA YO‘L QO‘YILADIGAN XATO VA KAMCHILIKLAR. (2026). MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE, 4(2), 135-145. https://universalpublishings.com/~niverta1/index.php/mpttp/article/view/16860
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Mazkur maqolada dori vositalarini tajribadan o‘tkazish jarayonida uchraydigan asosiy xato va kamchiliklar ilmiy tahlil qilinadi. Tadqiqotda preklinik va klinik bosqichlarda yo‘l qo‘yiladigan metodologik xatolar, statistik tahlildagi kamchiliklar, etik me’yorlarga rioya qilmaslik holatlari hamda postmarketing kuzatuvdagi muammolar ko‘rib chiqiladi. Shuningdek, xalqaro tashkilotlar tomonidan belgilangan talab va standartlarning ahamiyati yoritilib, dori vositalarining xavfsizligi va samaradorligini ta’minlashda ilmiy asoslangan yondashuv zarurligi asoslab beriladi.

PDF
DOI

References

1. World Health Organization. Guidelines for Good Clinical Practice. Geneva: WHO; 2021.

2. U.S. Food and Drug Administration. Guidance for Industry: Clinical Trials. Silver Spring, MD: FDA; 2020.

3. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Geneva: WMA; 2013.

4. ICH. ICH Harmonised Guideline: Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). Geneva: International Council for Harmonisation; 2016.

5. Katzung, B.G., Masters, S.B., Trevor, A.J. Basic & Clinical Pharmacology, 15th Edition. New York: McGraw-Hill Education; 2021.

6. Rang, H.P., Dale, M.M., Ritter, J.M., Flower, R.J., Henderson, G. Rang & Dale’s Pharmacology, 9th Edition. London: Elsevier; 2020.

7. Finkel, R., Cubeddu, L., Clark, M. Lippincott Illustrated Reviews: Pharmacology, 8th Edition. Philadelphia: Wolters Kluwer; 2020.

8. Brunton, L.L., Hilal-Dandan, R., Knollmann, B.C. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 14th Edition. New York: McGraw-Hill; 2021.